Dasatinib-Blinatumomab for Ph-Positive ALL. Reply
- PMID: 33503352
- DOI: 10.1056/NEJMc2033785
Dasatinib-Blinatumomab for Ph-Positive ALL. Reply
Comment on
-
Dasatinib-Blinatumomab for Ph-Positive ALL.N Engl J Med. 2021 Jan 28;384(4):384. doi: 10.1056/NEJMc2033785. N Engl J Med. 2021. PMID: 33503351 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources